Laura Housman

Chief Clinical Strategy Officer

Laura has dedicated her career to ensuring equal, meaningful and affordable access to healthcare innovation, drawing upon her deep experience across the healthcare continuum. Across her work at BCBS of MA, a market-dominant and innovator payer, Genzyme Genetics, a market leader in Women’s Health and Cancer esoteric testing, Charles River Laboratories, a world-renowned drug development research organization, Novartis, an innovator in developing and marketing some of the world’s most effective therapies, Molecular Health, an innovator in data and analytic digital health, Laura has provided strategies and solutions for healthcare innovation and expedited delivery to those that are seeking access to life-changing offerings – patients and their caregivers.

Most recently as CEO and Founder of Access Solutions Consulting, Laura has provided strategies and solutions for all areas of healthcare commercialization, reimbursement and access support, with particular expertise and extensive network in companion and complementary Dx; precision medicine; patient communications; corporate, business and network development; pharmaceutical and biotech drug development and drug safety access initiatives.